Details of the Drug
General Information of Drug (ID: DMCIA40)
Drug Name |
1-Thiazol-2-yl-3-(2-p-tolyl-ethyl)-thiourea
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL149100; 149484-92-4; Thiourea, N-[2-(4-methylphenyl)ethyl]-N'-2-thiazolyl-; AC1MHEHT; ACMC-20n5ps; 1-Thiazol-2-yl-3-(2-p-tolyl-ethyl)-thiourea; SCHEMBL6284717; CTK0B1828; DTXSID70388246; BDBM50097037; AKOS030030944; 1-[2-(p-tolyl)ethyl]-3-thiazol-2-yl-thiourea; 1-(4-Methylphenethyl)-3-(2-thiazolyl)thiourea; [2-(4-Methylphenyl)ethyl]-N''-[2-(thiazolyl)]thiourea
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 277.4 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||